Dongfeng Qu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Cancer Stem Cells

Transforming Growth Factor

Long Noncoding Rna

Top Venues

International journal of molecular sciences

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Landon L Moore, Dongfeng Qu, Sripathi Sureban, Stephanie Mitchell, Kamille Pitts, Nasya Cooper, Javid Fazili, Richard Harty, Abdul Oseini, Kai Ding, Michael Bronze, Courtney W Houchen
From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. International journal of molecular sciences 25 (12) (2024)
Landon L Moore, Dongfeng Qu, Sripathi Sureban, Stephanie Mitchell, Kamille Pitts, Nasya Cooper, Javid Fazili, Richard Harty, Abdul Oseini, Kai Ding, Michael Bronze, Courtney W Houchen
From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. International journal of molecular sciences 25 (12) (2024)
Landon L Moore, Dongfeng Qu, Sripathi Sureban, Stephanie Mitchell, Kamille Pitts, Nasya Cooper, Javid Fazili, Richard Harty, Abdul Oseini, Kai Ding, Michael Bronze, Courtney W Houchen
From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. International journal of molecular sciences 25 (12) (2024)
Ling Ding, Yuning Yang, Qin Lu, Dongfeng Qu, Parthasarathy Chandrakesan, Hailan Feng, Hong Chen, Xuzheng Chen, Zhuhui Liao, Jian Du, Zhiyun Cao, Nathaniel Weygant
Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial-Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis. International journal of molecular sciences 23 (21) (2022)
Zhiyun Cao, Nathaniel Weygant, Parthasarathy Chandrakesan, Courtney W Houchen, Jun Peng, Dongfeng Qu
Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment. Cancers 12 (12) (2020)
Dongfeng Qu, Nathaniel Weygant, Jiannan Yao, Parthasarathy Chandrakesan, William L Berry, Randal May, Kamille Pitts, Sanam Husain, Stan Lightfoot, Min Li, Timothy C Wang, Guang Yu An, Cynthia Clendenin, Ben Z Stanger, Courtney W Houchen
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer. Journal of oncology 2019 (2019)